Eton Pharmaceuticals (ETON) Cash from Operations Growth (3y) (2021 - 2025)
Eton Pharmaceuticals (ETON) Cash from Operations Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 34.90% |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | -9.94% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -10.80% |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn | 7.32% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -26.33% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 46.81% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 27.85% |
| 10 | Eton Pharmaceuticals | 1.15 Bn | 1.12 Bn | 13.10 Mn | -82.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -82.39% |
| Sep 30, 2025 | 108.48% |
| Jun 30, 2025 | 47.88% |
| Mar 31, 2025 | 19.56% |
| Dec 31, 2024 | 46.93% |
| Sep 30, 2024 | 44.24% |
| Jun 30, 2024 | 75.45% |
| Mar 31, 2024 | -38.66% |
| Dec 31, 2023 | 27.11% |
| Sep 30, 2023 | 29.49% |
| Jun 30, 2023 | 64.97% |
| Mar 31, 2023 | 40.14% |
| Dec 31, 2022 | 39.90% |
| Sep 30, 2022 | 19.09% |
| Jun 30, 2022 | 37.27% |
| Mar 31, 2022 | 29.68% |
| Dec 31, 2021 | -42.35% |
| Sep 30, 2021 | -8.76% |
| Jun 30, 2021 | 45.08% |
| Mar 31, 2021 | 58.85% |